Loading insider details...
Beta
Latest Form 4 (Oct 15, 2026): Exercise/Conversion of 17,000 REGN shares, $6.49M.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 15, 2026 | REGENERON PHARMACEUTICALS, INC. (REGN) | Exercise/Conversion | 17,000 | $6.49M |
| Dec 11, 2025 | REGENERON PHARMACEUTICALS, INC. (REGN) | Tax Withholding | 4,229 | $2.97M |
| Dec 9, 2025 | REGENERON PHARMACEUTICALS, INC. (REGN) | Grant/Award | 3,715 | n/a |
| Oct 31, 2025 | REGENERON PHARMACEUTICALS, INC. (REGN) | Exercise/Conversion | 35,000 | $19.45M |
| Dec 18, 2024 | REGENERON PHARMACEUTICALS, INC. (REGN) | Tax Withholding | 1,054 | $770.3K |
| Dec 10, 2024 | REGENERON PHARMACEUTICALS, INC. (REGN) | Grant/Award | 3,499 | n/a |
| Nov 12, 2024 | REGENERON PHARMACEUTICALS, INC. (REGN) | Gift | 1,185 | n/a |
| Aug 15, 2024 | REGENERON PHARMACEUTICALS, INC. (REGN) | Exercise/Conversion | 20,000 | $7.99M |
| Mar 15, 2024 | REGENERON PHARMACEUTICALS, INC. (REGN) | Exercise/Conversion | 20,000 | $7.99M |
| Dec 14, 2023 | REGENERON PHARMACEUTICALS, INC. (REGN) | Tax Withholding | 7,657 | $6.56M |